IBRX
ImmunityBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.19
−6.29%Leverage
- Debt / equity
- -0.78x
- Net debt / equity
- -0.70x
- Debt / assets
- 1.29x
- Debt / EBITDA
- -0.91x
- Net debt / EBITDA
- -0.83x
Liquidity & coverage
- Current ratio
- 5.72x
- Quick ratio
- 5.70x
- Cash ratio
- 4.66x
- Interest coverage
- -3.02x
- EBITDA / interest
- -10.72x
- Working capital
- $362.3M
Cash & dividend
- FCF / debt
- -0.35x
- Cash flow / debt
- -0.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026